Oxolinic acid

SKU: orb1309290

Description

Oxolinic acid

Research Area

Cell Biology, Infectious Disease & Virology, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 14698-29-4
• MW: 261.23
• Purity: 99.72%
• Formula: C₁₃H₁₁NO₅
• SMILES: CCn1cc(C(O)=O)c(=O)c2cc3OCOc3cc12
• Target: DNA/RNA Synthesis,Antibiotic,Dopamine Receptor,Antibacterial
• Solubility: DMSO:< 1 mg/mL (insoluble or slightly soluble)

Bioactivity

• Target IC50:
  Dopamine uptake:4.3 μM
• In Vivo:
  The antimicrobial agent oxolinic acid, injected i.p. In mice, induces a dose dependent increase in locomotor activity the stimulant locomotor effect of oxolinic acid depends o the blockade o the neuronal dopamine uptake comple.
• In Vitro:
  Oxolinic acid, a quinolone antibacterial agent, inhibits reversibl the ATP-dependent replicative DNA synthesis in permeable cell systems as well as in cellophane disk lysate . It also inhibits bacterial DNA gyrase but not eukaryotic topoisomerases, reversibly binding gyrase subunit A in gyrase-DNA complexes, blocking supercoiling activity and inhibiting DNA synthesis at 0.5-5 μg/m [5 [6 [7].

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Disclaimer: For research use only

Alternative Names

antimicrobial, Antibiotic, Bacterial, bacterial DNA gyrase, Dopamine Receptor, dopamine, dopamine uptake, DopamineReceptor, DNASynthesis, DNA synthesis, DNA Synthesis, DNA/RNA Synthesis, DNA/RNA, Dioxacin, Oxolinic acid, Nidantin, infections, inhibit, NSC110364, NSC-110364, NSC 110364, Emyrenil, Inhibitor, synthesis, tract, RNASynthesis, RNA Synthesis, urinary, Urinox, uptake

Compound Identifiers

PubChem CID

4628